RxDoctor Payments Data

Thomas Bernasek, MD

Orthopaedic Surgery · Temple Terrace, FLNPI 1881699726

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $5,892,094 of the $6,355,070 with a category attached, or 92.7%. Depuy Synthes Products, Inc. accounts for 94.9% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $1,448,779 and has fallen 52.7% since, to $685,354 in 2025. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,355,070in general payments, 2019–2025

Across 343 payments — averaging $18,528 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$6M
  • Medical Device Business Services, Inc.$314K
  • Corin USA$3K
  • Johnson & Johnson$1K
  • Zimmer Biomet$815
  • Stryker$641
  • plus $3K from 14 others
$81,365in research payments, 2019–2025

Across 75 payments — averaging $1084.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$69K
  • Depuy Synthes Products, Inc.$12K

What the payments were for

  • Royalty or licence$5,892,09493%
  • Consulting fees$414,2617%
  • Travel & lodging$40,8831%
  • Food & beverage$7,8330%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,355,070 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$579,231
Medicare patients
835
Services billed
13,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib26$867
Meloxicam113$309
Amoxicillin117$204
Clindamycin Hcl21$27

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Temple Terrace

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →